Clinical Trials Logo

Cystostomy; Complications clinical trials

View clinical trials related to Cystostomy; Complications.

Filter by:
  • Not yet recruiting  
  • Page 1

NCT ID: NCT04219046 Not yet recruiting - Bladder Cancer Clinical Trials

Evaluation of Naloxegol in the Prevention of POI After Cystectomy

ANTAGOCYST
Start date: March 2021
Phase: Phase 2
Study type: Interventional

Postoperative ileus (POI) is defined as a transient reduction of bowel motility that prevents effective transit of bowel content and tolerance of oral intake following surgical interventions, especially after radical cystectomy. It remains a major factor associated with postoperative morbidity, length of hospital stay and medical costs. In order to optimize perioperative care for patients undergoing radical cystectomy in a context of an ERAS (Enhanced Recovery After Surgery) program, we will evaluate the effectiveness of systemic pharmacologic opioid antagonist treatment.